Clofazimine-induced Hair Pigmentation
- PMID: 23180930
- PMCID: PMC3500060
- DOI: 10.4103/0974-7753.100088
Clofazimine-induced Hair Pigmentation
Abstract
A 45-year-old man was treated with WHO multibacillary multidrug therapy for borderline leprosy and high dose daily Clofazimine for lepra reaction. Along with the expected side effect of skin pigmentation, the patient also noticed darkening of previously grey hair. This colour persisted eight months after completing multibacillary multidrug therapy.
Keywords: Borderline leprosy; clofazimine; hair pigmentation.
Conflict of interest statement
Figures
References
-
- Jopling WH, McDougall AC. Chemotherapy. In: Jopling WH, McDougall A C, editors. Handbook of Leprosy. 5th ed. New Delhi: C B S Publishers; 1996. pp. 101–7.
-
- Browne SG, Hogerzeil LM. B663 in the treatment of leprosy: Preliminary report of a pilot trial. Lepr Rev. 1962;33:6–10. - PubMed
-
- Yawalker SJ, Bischer W. Lamprene [Clofazimine] in Leprosy. Lepr Rev. 1979;50:135–44. - PubMed
-
- Petri WA. Antimicrobial agents: Drugs used in TB, MAC and Leprosy. In: Hardman JG, Linbird LE, editors. The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw Hill Publications; 2001. p. 1290.
-
- Levy L. Pharmacological studies of Clofazimine. Am J Trop Med Hyg. 1974;23:1097–109. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources